Our attempts to simulate CRC treatment-induced global activation of T cells by stimulating T cells with microbeads, supported concurrent upregulation of CD80 and PD-L1 on APCs, regardless of whether they were from colon, tumor or blood. Here, CD80 is linked to neoplasm.